Informed Consent
Item
the patients signed the written informed consent
boolean
C0021430 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma Operable TNM clinical staging | EGFR Exon 19 Mutation | EGFR Exon 21 Mutation
Item
the patients present with operable stage ii-iiia non-small-cell lung cancers with 19 or 21 exon mutation
boolean
C0007131 (UMLS CUI [1,1])
C0205188 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C4289656 (UMLS CUI [2])
C4289654 (UMLS CUI [3])
Cancer treatment Absent | Chemotherapy Absent | Therapeutic radiology procedure Absent
Item
the patients have no history of anti-cancer therapies including chemotherapy, radiation therapy
boolean
C0920425 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
ECOG performance status
Item
the patients' eastern cooperative oncology group scores are ≤ 0-2
boolean
C1520224 (UMLS CUI [1])
Neoplasm Unresected
Item
patients with unresected tumor
boolean
C0027651 (UMLS CUI [1,1])
C2986425 (UMLS CUI [1,2])
EGFR gene Wild Type
Item
wild egfr type
boolean
C1414313 (UMLS CUI [1,1])
C1883559 (UMLS CUI [1,2])
Hypersensitivity Investigational New Drugs
Item
allergic to the study drug
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Disease Severe | Exception Malignant Neoplasms
Item
patients have severe non-cancerous diseases
boolean
C0012634 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
Cancer treatment | Study Subject Participation Status
Item
patients are undergoing current administration of anti-cancer therapies, or are attending some other clinical trials
boolean
C0920425 (UMLS CUI [1])
C2348568 (UMLS CUI [2])